Patients with genotype *2/*2 (poor metabolizer) showed a trend towards higher levels of miR-126-3p and miR-185-5p (approximately 1.5 to 1.7 times) compared to *1/*1 (wild type).
← all excerpts
Pathophysiology of Clopidogrel in Ischemic Stroke, Role of Platelet microRNAs.
1
—
—